Front Row Advisors’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
NI
Front Row Advisors's QGEN Position: Q3 2024 in Review
Front Row Advisors sold out of Qiagen (QGEN) in Q3 2024, closing a stake of 58 shares — an estimated $2.46K sold.
Front Row Advisors first reported a position in QGEN in Q4 2017 and held it in 26 quarters. The position peaked at $12K in Q1 2018. 329 funds tracked by Wall St. Rank hold QGEN as of Q3 2024.
- Front Row Advisors reported no remaining Qiagen position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 58 Qiagen shares in Q3 2024, an estimated $2.46K.
- Front Row Advisors first reported a position in Qiagen in Q4 2017 and held it in 26 quarters.
- Front Row Advisors's Qiagen position peaked at $12K in Q1 2018.
- 329 funds tracked by Wall St. Rank held Qiagen as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.